Walleye Trading
VNDA icon

Walleye Trading’s Vanda Pharmaceuticals VNDA Stock Holding History

Walleye Trading’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-6,600
Closed -$65K – 5448
2022
Q3 		$65K Hold
6,600
– – ﹤0.01% 4188
2022
Q2 		$72K Sell
6,600
-6,700
-50% -$69.4K ﹤0.01% 4219
2022
Q1 		$150K Sell
13,300
-6,800
-34% -$89.4K ﹤0.01% 4006
2021
Q4 		$315K Buy
20,100
+4,000
+25% +$69.7K ﹤0.01% 3442
2021
Q3 		$276K Buy
+16,100
New +$282K ﹤0.01% 3540
2020
Q1 		– Sell
-5,300
Closed -$87K – 4629
2019
Q4 		$87K Buy
+5,300
New +$80.1K ﹤0.01% 3622
2019
Q1 		– Sell
-12,400
Closed -$324K – 4807
2018
Q4 		$324K Buy
12,400
+6,200
+100% +$146K ﹤0.01% 2903
2018
Q3 		$142K Buy
+6,200
New +$127K ﹤0.01% 3996
2018
Q1 		– Sell
-37,500
Closed -$569 – 4837
2017
Q4 		$569 Buy
+37,500
New +$557K ﹤0.01% 2488

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Walleye Trading's VNDA Position: Q3 2022 in Review

Walleye Trading sold out of Vanda Pharmaceuticals (VNDA) in Q3 2022, closing a stake of 5,072 shares — an estimated $53.6K sold.

Walleye Trading first reported a position in VNDA in Q1 2016 and held it in 10 quarters. The position peaked at $510K in Q4 2016. 178 funds tracked by Wall St. Rank hold VNDA as of Q3 2022.

  • Walleye Trading reported no remaining Vanda Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Walleye Trading sold 5,072 Vanda Pharmaceuticals shares in Q3 2022, an estimated $53.6K.
  • Walleye Trading first reported a position in Vanda Pharmaceuticals in Q1 2016 and held it in 10 quarters.
  • Walleye Trading's Vanda Pharmaceuticals position peaked at $510K in Q4 2016.
  • 178 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2022.

Based on Walleye Trading's 13F filing for Q3 2022, filed 14 Nov 2022.